Adial Pharmaceuticals Inc
Organization details
- Legal name
- Adial Pharmaceuticals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Charlottesville
- Headquarters state / province
- Virginia
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ADIL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001513525
- EIN
- 80-0667150
Board of directors
-
Aida Habtezion · DirectorSince 2026
-
Bankole A. Johnson · DirectorSince 2023
-
Cary J. Claiborne · Director · Chief Executive OfficerSince 2023
-
J. Kermit Anderson · DirectorSince 2023
-
James W. Newman Jr. · DirectorSince 2023
-
Kevin Schuyler · DirectorSince 2023
-
Matt Davidson · Director · President and CEOSince 2026
-
Paul J. Hastings · DirectorSince 2026
-
Robertson H. Gilliland · DirectorSince 2023
-
Thomas M. Soloway · DirectorSince 2026
-
Tony Goodman · Director · Chief Operating OfficerSince 2023
-
Wendy B. Young · DirectorSince 2026
-
William B. Stilley III · DirectorSince 2023
Chief executives
Director election results
Annual meeting of September 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.9%
-
99.4%
Board connections
5 of this board's directors also sit on 7 other boards. 5 are in the same sector.
- via William B. Stilley III
-
NeuroSense Therapeutics Ltd. Same sectorvia Cary J. Claiborne
-
Nkarta Inc. Same sectorvia Paul J. Hastings
-
Pacira BioSciences Inc. Same sectorvia Paul J. Hastings
-
Rapport Therapeutics Inc. Same sectorvia Wendy B. Young
- via Kevin Schuyler
-
enGene Therapeutics Inc. Same sectorvia Paul J. Hastings
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $106,329
- 5 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Saiki Julie Officer (Chief Strategy Officer) | Derivative conversion | +626,252 | — | — |
| Nov 2, 2026 | Matt Davidson Director, Officer (President and CEO) | Derivative conversion | +524,954 | — | — |
| Nov 2, 2026 | Matt Davidson Director, Officer (President and CEO) | Derivative conversion | +101,298 | — | — |
| Oct 28, 2026 | Matt Davidson Director, Officer (President and CEO) | Grant or award | +232,417 | — | — |
| Jul 16, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +1,233 | $2.75 | $3,391 |
| Jul 14, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +2,000 | $2.65 | $5,300 |
| Jul 10, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +1,700 | $2.70 | $4,590 |
| Jul 9, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +10,053 | $2.79 | $28,048 |
| Jun 29, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +25,000 | $2.60 | $65,000 |
| Jun 12, 2026 | Matt Davidson Director, Officer (Chief Development Officer) | Grant or award | +232,417 | — | — |
| Jun 11, 2026 | Matt Davidson Director, Officer (Chief Development Officer) | Grant or award | +61,647 | — | — |
| Jun 11, 2026 | Matt Davidson Director, Officer (Chief Development Officer) | Grant or award | +3,427 | — | — |
| Jun 11, 2026 | Matt Davidson Director, Officer (Chief Development Officer) | Grant or award | +1,822 | — | — |
| Jun 11, 2026 | Matt Davidson Director, Officer (Chief Development Officer) | Grant or award | +101 | — | — |
| Apr 7, 2026 | Tony Goodman Director, Officer (Chief Operating Officer) | Grant or award | +26,510 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Adial Pharmaceuticals Inc
Who is the CEO of Adial Pharmaceuticals Inc?
Cary J. Claiborne is Adial Pharmaceuticals Inc's Chief Executive Officer.
How many directors are on Adial Pharmaceuticals Inc's board?
Adial Pharmaceuticals Inc's board has 13 directors: Aida Habtezion, Bankole A. Johnson, Cary J. Claiborne, J. Kermit Anderson, James W. Newman Jr., Kevin Schuyler, Matt Davidson, Paul J. Hastings, Robertson H. Gilliland, Thomas M. Soloway and 3 others.
Are Adial Pharmaceuticals Inc insiders buying or selling shares?
Over the last 12 months, Adial Pharmaceuticals Inc insiders bought $106,329 of shares in 5 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="adial-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.